HNSS is having the manufacturer of their product produce, disperse and sell it. HNSS will only get a royalty from those sales. Thus HNSS doesn't incur any cost associated with the production, dispersal or sales of their product. The company hired to manufacture HNSS's product on an international scale incurs the cost.
I agree. Like I said before, I won't get overly excited until I see the funds in my bank account. I do think that it is important to continue DD however. There aren't very many international medical product manufacturers in the Fortune 500. I think Baxter International is one of the more likely companies that HNSS is working with.
Market Data 
Markets 
AI
